407.3 ð©º å §ç§å°ç§èåç
407.3.0.1 ð äžé éé»
- 22E: ethnicity-specific Ferriman-Gallwey thresholds; ACTH stim test for borderline 17-OH-prog; AMH for PCOS confirmation; spironolactone safety in non-pregnant; eflornithine 13.9%
- Taiwan: å¥ä¿ spironolactone, COC, dexamethasone, dexamethasone for CAH; eflornithine èªè²» å€
407.3.0.2 ð Pearls (10)
- Asian / Taiwanese women lower Ferriman-Gallwey threshold (~ 5 may be abnormal vs 8 in white)
- Free T: more sensitive than total T in obesity (low SHBG)
- 17-OH-prog post-ACTH stim required if basal borderline (200-300 ng/dL)
- Spironolactone monitoring: K (especially with ACE-i/ARB combo), renal function
- Spironolactone slow onset: 6-12 mo for full hair benefit
- COC + spironolactone superior to either alone for hirsutism
- Finasteride 2.5-5 mg effective; lower dose may be sufficient
- Bicalutamide for refractory cases (off-label, less hepatotoxic than flutamide)
- Inositol + metformin for PCOS-related hirsutism (modest)
- Eflornithine 13.9% topical: 4-8 weeks for benefit; combine with mechanical removal
407.3.0.3 ð Taiwan + å¥ä¿
- å¥ä¿ spironolactone å€ ($
- å¥ä¿ COC (multiple types)
- å¥ä¿ dexamethasone, hydrocortisone for CAH
- å¥ä¿ finasteride (off-label hirsutism)
- å¥ä¿ metformin
- Eflornithine 13.9% cream èªè²» å€
- Cyproterone acetate èªè²» (not approved Taiwan)
- å¥ä¿ laser hair removal æ¢ä»¶ (selected; cosmetic generally not covered)
- å¥ä¿ hormone panel + imaging workup
407.3.0.4 ð å §å°å¿ æ (10)
- Hirsutism workup algorithm + æé€ tumor, CAH, Cushingâs
- Free T + DHEA-S + 17-OH-prog interpretation
- Tumor red flags + imaging
- Non-classic CAH diagnosis (basal + post-ACTH 17-OH-prog)
- PCOS-related hirsutism + comprehensive PCOS workup
- Spironolactone + COC combination + monitoring
- Pregnancy planning + anti-androgen contraindications
- Eflornithine + laser + electrolysis combined approach
- Idiopathic hirsutism + ethnicity adjustment
- 22E: AMH, free T sensitivity in obesity, bicalutamide, inositol
407.3.0.5 âïž Workup Algorithm (å §å°)
Step 1 â Confirm Hirsutism + Severity
- Ferriman-Gallwey scoring (ethnicity-adjusted)
- Distinguish from hypertrichosis (lanugo) and virilization
Step 2 â History + Exam
- Onset (gradual vs sudden)
- Drug history
- Menstrual pattern
- Cushing's signs
- Virilization
Step 3 â Hormone Panel
- Total T (or Free T if obese)
- DHEA-S
- 17-OH-progesterone (basal, AM, follicular phase)
- Prolactin
- TSH
- Cushing screening if symptomatic (1mg dex / 24h urine cortisol)
- HbA1c, lipid (PCOS metabolic)
Step 4 â Specific Tests
- 17-OH-prog basal 200-300 â ACTH stim test (suppress = normal; > 1000 = CAH)
- Free T calculated (with SHBG) if SHBG suspected abnormal
- Pelvic US (PCOS or ovarian tumor)
- Adrenal CT/MRI if T > 200 or DHEA-S > 700
Step 5 â Treatment
- Lifestyle for PCOS
- Mechanical hair removal (shaving/waxing/electrolysis/laser)
- Eflornithine cream (slow growth)
- Medical: COC + spironolactone
- Specific: HC for CAH, surgery for tumor, treat Cushing's
407.3.0.6 âïž Pregnancy + Hirsutism
- Spironolactone: teratogenic (feminize male fetus) â stop pre-conception
- Finasteride: teratogenic (genital malformation) â stop
- Flutamide: teratogenic â stop
- Cyproterone: teratogenic
- COC: stop when planning conception
- Metformin: continue if PCOS (improves cycle, no major teratogenic concern)
- HC for CAH: continue (essential)
- Lifestyle + mechanical hair removal safe
â ïž AI èçš¿ã